Want to join the conversation?
In 3Q15, $MBLY's EyeQ chip volume increased 110% YoverY to about 1,351,000 EyeQ units versus 642,000 units in 3Q14. OEM ASP was $43.5, up from $43.2 last year same period, mainly attributable to product mix & product deliveries. For 2015, annual ASP is expected to be relatively flat versus 2014, in line with estimates previously provided.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.